期刊文献+

核包膜蛋白gp210自身抗原基因的克隆、表达、纯化及其临床应用 被引量:3

Cloning and Expression of Nuclear Envelope Protein gp210 Autoantigene Gene Purification as well as Clinical Application of the Recombinant protein
下载PDF
导出
摘要 目的研究核包膜蛋白gp210基因在大肠杆菌中的稳定表达、纯化和免疫学活性鉴定。方法从人外周血单个核细胞中提取细胞总RNA,应用RT-PCR方法扩增gp210蛋白中含优势表位的基因片段。将该段基因克隆入PET-30a表达载体并转化到大肠杆菌BL21中表达。融合蛋白经Ni-NAT树脂柱进行亲和层析纯化,并通过SDS-PAGE电泳及ELISA方法进行鉴定。结果在原核表达载体中成功构建了PET30a-gp210重组体。重组体诱导培养后,SDS-PAGE电泳分析可见在相对分子量大约69 kD处有gp210融合蛋白的高效表达,经纯化获得纯度达90%的表达蛋白。ELISA检测结果显示该重组蛋白具有较好的抗原性和特异性。结论应用基因工程方法,获得了gp210重组蛋白,为检测抗gp210抗体提供了特异性抗原,也为临床将抗gp210抗体作为PBC的特异性诊断指标奠定了基础。 Objective To express, purify nuclear envelope protein gp210 gene in E. coil, and identify its immunoactivity. Methods Gene fragment of nuclear envelope protein gp210 containing the predominant autoepitope was amplified by extract/ng total RNA from human peripheral blood mononuclear cell and RT-PCR. The target gene was cloned into the expressive vector PET-30a and tronsformated into E coli BL21. The recombinant was induced by IPTG to express target protein. This fusion protein was purified by NAT chromatography and identified by SDS-PAGE and ELISA. Results The plasmid PET30a-gp210 was reconstructed successfully and expressed a Mr 69kD gp210 fusion protein in E. toll by seeing a single special strip on SDS-PAGE gel. It reached a purity of 90% by purification. The result of ELISA showed its good antigenicity and specificity. Conclusion Using the method of gene engineering, we obtain recombinant polypeptide. It can be used as diagnostic material to develop a simple assay to detect gp210 autoantibodies for its good antigenicity. It also provides test reference for clinical diagnosis of PBC.
出处 《中国实验诊断学》 2007年第10期1343-1346,共4页 Chinese Journal of Laboratory Diagnosis
关键词 原发性胆汁性肝硬化 GP210 核包膜蛋白 基因表达 重组蛋白 primary biliary cinbosis(PBC) gp210 nuclear envelope protein gene expression recombinant protein
  • 相关文献

参考文献6

  • 1Metcalf JV,Bhopal RS,Gray J,et al.Incidence and prevalence of primary biliary cirrhosis in the city of Newcastle-upon-Tyne,England[J].Int F Epidemiol,1997,26:830. 被引量:1
  • 2Lassoued K,Brenard R,Degos R et al.Antinuclear antibodies directed to a 200 kD polypeptide of the muclear envelope in primary biliary cirrhosis.a clinical and immunological study of a series of 150 patients with primary biliary cirrhosis[ J].Gastroenterology,1990,99:181. 被引量:1
  • 3Bandin O,Courvalin JC et al.Specificity and sensitivity of gp210 autoantibodies detected using an enzymee-linked immunosorbent assay and a synthetic polypeptide in the diagnosis of primary biliary cirrhosis[J].Hepatology,1996,23:1020. 被引量:1
  • 4Nickowitz RE,Worman HJ.Autoantibodies against integral membrane protein of the nuclear envelope in patients with primary biliary cirrhosis[J].Gastroenterology,1994; 106:193. 被引量:1
  • 5Wozniak RW,Bartnik E,Blobel G:Primary structure analysis of an integral membrane glycoprotein of the nuclear pore[J].J Cell Biol,1989,108:2083. 被引量:1
  • 6Tartakovsky F et al.Detection of gp210 autoantibodies in primary bidiary cirrhosis using a recombinant protein comtaining the predominant autoepitope[J].Hepatology,1995,21:495. 被引量:1

同被引文献45

  • 1李永哲 ,刘镭 ,孙庆国 ,曾常茜 ,赵振国 ,佟大伟 ,张蜀澜 ,高扬 ,于孟学 ,朱立平 .核包膜蛋白gp210、p62和LBR自身抗原基因克隆表达及其抗体诊断原发性胆汁性肝硬化的价值初探[J].中华检验医学杂志,2005,28(11):1120-1125. 被引量:9
  • 2谭爱国,高明,刘爱华.原发性胆汁性肝硬化患者血清中抗gp210抗体检测的临床意义[J].中国医师杂志,2006,8(12):1692-1693. 被引量:1
  • 3周晔,蒋天舒,陈燕,陈波,谷明莉,仲人前,邓安梅.自身抗原gp210融合蛋白的重组表达及其临床应用研究[J].中国实验诊断学,2007,11(6):739-742. 被引量:5
  • 4Bandin 0,Courvalin JC,Poupon R,et al. Specificity and sensitivityof GP210 autoantibodies detected using an enzyme-linked immu-nosorbent assay and a synthetic polypeptide in the diagnosis ofprimary biliary cirrhosis[J]. Hepatology, 1996 ,23(5) : 1020-1024. 被引量:1
  • 5Wong GL, Hui AY, Wong VW, et al. A retrospective study onclinical features and prognostic factors of biopsy-proven primarybiliary cirrhosis in Chinese patients[J]. Am J Gastroenterol,2005,100(10):2205-2211. 被引量:1
  • 6Hu C,Deng C, Song G,et al. Prevalence of autoimmune liver dis-ease related autoantibodies in Chinese patients with primary bili-ary cirrhosis[J], Dig Dis Sci,2011,56(11) :3357-3363. 被引量:1
  • 7Gao L,Tian X,Liu B,et al. The value of antinuclear antibodies inprimary biliary cirrhosis[J]. Clin Exp Med,2008,8(1) :9-15. 被引量:1
  • 8Heathcote EJ. Management of primary biliary cirrhosis. The A-merican Association for the Study of Liver Diseases practiceguidelines[J]. Hepatology,2000,31(4) :1005-1013. 被引量:1
  • 9European Association for the Study of the Liver. EASL ClinicalPractice Guidelines:management of cholestatic liver diseases[J]. JHepatol,2009,51(2) :237*267. 被引量:1
  • 10Feng Yang,Xuchao Xue,Jianwei Bi,Luming Zheng,Kangkang Zhi,Yan Gu,Guoen Fang.Long noncoding RNA CCAT1, which could be activated by c-Myc, promotes the progression of gastric carcinoma[J].Journal of Cancer Research and Clinical Oncology.2013(3) 被引量:5

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部